Evidence map›Paper›PMID 39264376›Full record

ArticleEJNMMI research2024

Potential application of [

Bliede Van den Broeck, Jens M Debacker, Wouter Bauters, David Creytens, Liesbeth Ferdinande, Wouter Huvenne, Bruno Lapauw, Vanessa Schelfhout, Nick Van Laeken, Charlotte Verroken

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05175404 (Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05175404 phase2completednot on this map

Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers

TypeinterventionalSponsorUniversity Hospital, GhentRan2022 to 2023Enrolled8ConditionsThyroid CancerArmsPET/CT scan F18-PSMA-11
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bliede Van den BroeckDepartment of Medical Imaging, Nuclear Medicine, Ghent University Hospital, C. Heymanslaan 10, 9000, Ghent, Belgium. bliede.vandenbroeck@uzgent.be.ORCID http://orcid.org/0000-0002-7235-9990
Jens M DebackerMolecular Imaging and Therapy Research Group (MITH), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Wouter BautersDepartment of Medical Imaging, Radiology, Ghent University Hospital, Ghent, Belgium.
David CreytensDepartment of Pathology, Ghent University Hospital, Ghent, Belgium.
Liesbeth FerdinandeDepartment of Pathology, Ghent University Hospital, Ghent, Belgium.
Wouter HuvenneDepartment of Head and Skin, Head and Neck Surgery Research Group, Ghent University, Ghent, Belgium.
Bruno LapauwDepartment of Endocrinology, Ghent University Hospital, Ghent, Belgium.
Vanessa SchelfhoutDepartment of Diagnostic Sciences, Ghent University, Ghent, Belgium.
Nick Van LaekenDepartment of Medical Imaging, Nuclear Medicine, Ghent University Hospital, C. Heymanslaan 10, 9000, Ghent, Belgium.
Charlotte VerrokenDepartment of Endocrinology, Ghent University Hospital, Ghent, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients diagnosed with radioiodine refractory (RAI-R) thyroid carcinoma (TC) have a significantly worse prognosis than patients with radiosensitive TC. These refractory malignancies are often dedifferentiated, hindering the effectiveness of iodine-based imaging. Additionally, the role of metabolic imaging using [

methodsIn this phase II study, lesions detected on [

resultsEight patients were included, with a total of 39 identified lesions based on PET imaging. [

conclusionsAlthough not all lesions could be visualized, [

Indexed as

PET/CTPSMA-11Radio-iodine refractory thyroid carcinomaThyroid carcinoma

Identifiers

PMID39264376
PMCPMC11393256

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.